Zebra BioSolutions Information

Zebra BioSolutions is a life sciences consulting and commercialization company helping medical device, biotechnology, and pharmaceutical innovators advance products from scientific development through regulatory authorization and market adoption. We provide integrated expertise across regulatory affairs, preclinical and clinical research, medical affairs, market readiness, commercialization, intellectual property, AI-assisted drug discovery, and sustainability. For medical device companies seeking access to the U.S. market, we provide FDA regulatory strategy and support, including regulatory pathway assessment, 510(k), De Novo and PMA strategy, predicate-device analysis, regulatory gap assessments, compliance readiness, and global-to-U.S. market-entry planning. We also support companies navigating regulatory requirements across the EU, Canada, Australia, Japan, and Brazil. Our Preclinical Research & Support and Clinical Research services help companies design evidence-generation strategies, evaluate development gaps, plan studies, identify research partners and investigators, interpret scientific and clinical data, and strengthen regulatory submissions. Our Medical Affairs and Medical Science Liaison (MSL) services help companies communicate scientific and clinical evidence effectively to physicians, surgeons, hospitals, investigators, and key opinion leaders. Services include medical affairs strategy, MSL deployment, KOL engagement, scientific exchange, medical education, scientist recruitment, MSL training, and field medical support. We also help companies prepare for commercialization through Market Readiness services, including competitive intelligence, product positioning, healthcare stakeholder engagement, launch planning, and U.S. market-entry strategy. Additional services include AI-Assisted Drug Discovery, IP Strategy & Due Diligence, and Good ESG & Sustainability Strategy. Our mission is to bridge science, regulation, and commercialization.